Add-on Treatment to Chemotherapy May Improve Acute Myeloid Leukemia Results
Acute myeloid leukemia (AML) is a type of blood cancer that arises from the blood forming cells of the bone marrow which usually form the white blood cells other than the lymphocytes. They may also form other cells like the red blood cells and the platelets. AML is the most common form of acute leukemia that affects adults. Treatment is with chemotherapy, radiotherapy and stem cell transplant. Targeted therapies are currently being evaluated in clinical trials. Nitric oxide synthase inhibitors could increase the effectiveness of chemotherapy administered for the treatment of acute myeloid leukemia, a type of blood cancer.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer